ASIA PACIFIC MULTIPLEX ASSAY MARKET FORECAST 2019-2027

  • You are here:
  • Home
  • Reports
  • ASIA PACIFIC MULTIPLEX ASSAY MARKET FORECAST 2019-2027

ASIA PACIFIC MULTIPLEX ASSAY MARKET FORECAST 2019-2027

The multiplex assay market of the Asia Pacific region is anticipated to witness a CAGR of 10.28% during the forecast period of 2019-2027. As this region is densely populated, there is growth in the market due to an increase in the demand in the health care infrastructure, a rising number of hospitals, healthcare reforms, technological advancements. These factors are expected to influence the growth of the market in the region. The market of India and China are expected to grow at the fastest rate during the forecast period due to the presence of highest population suffering from chronic diseases such as diabetes, tuberculosis, heart ailments, and others, a significant rise in the demand for quick diagnosis and research and development in the pharmaceutical sector. The overall multiplex assay market of Asia Pacific is further assessed on the basis of markets present in India, China, Japan, Australia, South Korea, and the rest of Asia Pacific.

ASIA PACIFIC MULTIPLEX ASSAY MARKET FORECAST 2019-2027

Request free sample

The multiplex assay market of the Asia Pacific region is anticipated to witness a CAGR of 10.28% during the forecast period of 2019-2027. As this region is densely populated, there is growth in the market due to an increase in the demand in the health care infrastructure, a rising number of hospitals, healthcare reforms, technological advancements. These factors are expected to influence the growth of the market in the region.

The market of India and China are expected to grow at the fastest rate during the forecast period due to the presence of highest population suffering from chronic diseases such as diabetes, tuberculosis, heart ailments, and others, a significant rise in the demand for quick diagnosis and research and development in the pharmaceutical sector.

The overall multiplex assay market of Asia Pacific is further assessed on the basis of markets present in India, China, Japan, Australia, South Korea, and the rest of Asia Pacific. The multiplex assay market of Japan is driven by government investment to encourage drug discovery and development. The Japanese government also promotes strategic alliances between key market players for the development of the market assay tests. Chinese pharmaceuticals are focusing on producing precision medicine, novel therapies, biomarkers, and multiplex assay. Many trends in the multiplex assay are coming up in China, one of the few countries in the world that requires patient samples in clinical tests. The Indian market is decided by a high number of clinical trials for cancer, along with government investments in promoting drug discovery activities. The clinical trials for cancer would increase the number of multiplex assay tests, and assays required to develop personalized medicines that detect biomarkers indicating specific therapies benefiting the patients.

One of the prominent companies in the market, Qiagen, provides assay technologies for molecular diagnostics, applied testing, and pharmaceutical research. The company has its presence in and operations in the Americas, the Middle East, Asia Pacific, Africa, Europe, and other parts of the world. The company has its headquarters in Venlo, the Netherlands.

To request a free sample copy of this report, please complete the form below:

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.

  1. RESEARCH SCOPE
    • STUDY GOALS
    • SCOPE OF THE MARKET STUDY
    • WHO WILL FIND THIS REPORT USEFUL?
    • STUDY AND FORECASTING YEARS
  2. RESEARCH METHODOLOGY
    • SOURCES OF DATA
      • SECONDARY DATA
      • PRIMARY DATA
    • TOP-DOWN APPROACH
    • BOTTOM-UP APPROACH
    • DATA TRIANGULATION
  3. EXECUTIVE SUMMARY
    • MARKET SUMMARY
    • KEY FINDINGS
      • NUCLEIC ACID-BASED MULTIPLEX ASSAYS ARE THE FASTEST GROWING TYPE
      • REAGENTS AND CONSUMABLES ARE THE WIDELY USED PRODUCTS
      • MULTIPLEX PCR IS THE VASTLY DEMANDING MULTIPLEX ASSAY TECHNOLOGY
      • MULTIPLEX ASSAYS ARE HIGHLY ECONOMICAL ASSAY
  1. MARKET DYNAMICS
    • MARKET SCOPE & DEFINITION
    • MARKET DRIVERS
      • GROWING R&D ACTIVITIES & GOVERNMENTAL FUNDING
      • PREFERENCE OF MULTIPLEX ASSAYS OVER CONVENTIONAL ASSAYS
      • INCREASED IN THE ADOPTION OF PERSONALIZED MEDICINES
    • MARKET RESTRAINTS
      • LACK OF SKILLED PROFESSIONALS
    • MARKET OPPORTUNITIES
      • GROWING OPPORTUNITIES IN THE EMERGING ECONOMIES
      • IDENTIFICATION OF NOVEL BIOMARKERS
    • MARKET CHALLENGES
      • STRINGENT REGULATIONS
  1. MARKET BY TYPE
    • PROTEIN-BASED MULTIPLEX ASSAYS
    • NUCLEIC ACID-BASED MULTIPLEX ASSAYS
    • OTHER MULTIPLEX ASSAYS
  2. MARKET BY PRODUCT
    • REAGENTS AND CONSUMABLES
    • INSTRUMENTS AND ACCESSORIES
    • SOFTWARE AND SERVICES
  3. MARKET BY TECHNOLOGY
    • MULTIPLEX PROTEIN MICROARRAY
    • MULTIPLEX PCR
    • OTHER TECHNOLOGY
  4. MARKET BY APPLICATION
    • CLINICAL DIAGNOSTICS
    • RESEARCH AND DEVELOPMENT
    • COMPANION DIAGNOSTICS
  5. MARKET BY END-USER
    • HOSPITALS
    • CLINICAL LABORATORIES
    • RESEARCH INSTITUTES
    • PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
  6. KEY ANALYTICS
    • PORTER’S FIVE FORCES MODEL
      • THREAT OF NEW ENTRANTS
      • THREAT OF SUBSTITUTE PRODUCTS
      • BARGAINING POWER OF BUYER
      • BARGAINING POWER OF SUPPLIER
      • INTENSITY OF COMPETITIVE RIVALRY
    • KEY BUYING CRITERIA
    • KEY TRENDS
    • OPPORTUNITY MATRIX
  7. GEOGRAPHICAL ANALYSIS
    • ASIA PACIFIC
      • JAPAN
      • CHINA
      • INDIA
      • SOUTH KOREA
      • AUSTRALIA
      • REST OF ASIA-PACIFIC
  1. COMPETITIVE LANDSCAPE
    • MARKET SHARE ANALYSIS
    • COMPANY PROFILES
      • ABCAM PLC.
      • AGILENT TECHNOLOGIES, INC.
      • BECTON DICKINSON AND COMPANY
      • BIO-RAD LABORATORIES, INC.
      • BIO-TECHNE CORPORATION
      • ILLUMINA, INC
      • LUMINEX CORPORATION
      • MERCK MILIPORE
      • MESO SCALE DIAGNOSTICS, LLC
      • OLINK PROTEOMICS AB
      • QIAGEN N.V.
      • RANDOX LABORATORIES LTD.
      • SEEGENE INC.
      • SIEMENS HEALTHINEERS
      • THERMO FISHER SCIENTIFIC INC.

LIST OF TABLES

TABLE 1: ASIA PACIFIC MULTIPLEX ASSAY MARKET, 2019-2027 ($ MILLION)

TABLE 2: ASIA PACIFIC MULTIPLEX ASSAY MARKET, BY TYPE, 2019-2027 ($ MILLION)

TABLE 3: ASIA PACIFIC PROTEIN-BASED MULTIPLEX ASSAYS MARKET, 2019-2027 ($ MILLION)

TABLE 4: ASIA PACIFIC NUCLEIC ACID-BASED MULTIPLEX ASSAYS MARKET, 2019-2027 ($ MILLION)

TABLE 5: ASIA PACIFIC OTHER MULTIPLEX ASSAYS MARKET, 2019-2027 ($ MILLION)

TABLE 6: ASIA PACIFIC MULTIPLEX ASSAY MARKET, BY PRODUCT, 2019-2027 ($ MILLION)

TABLE 7: ASIA PACIFIC REAGENTS AND CONSUMABLES MARKET, 2019-2027 ($ MILLION)

TABLE 8: ASIA PACIFIC INSTRUMENTS AND ACCESSORIES MARKET, 2019-2027 ($ MILLION)

TABLE 9: ASIA PACIFIC SOFTWARE AND SERVICES MARKET, 2019-2027 ($ MILLION)

TABLE 10: ASIA PACIFIC MULTIPLEX ASSAY MARKET, BY TECHNOLOGY, 2019-2027 ($ MILLION)

TABLE 11: ASIA PACIFIC MULTIPLEX PROTEIN MICROARRAY MARKET, 2019-2027 ($ MILLION)

TABLE 12: ASIA PACIFIC MULTIPLEX PCR MARKET, 2019-2027 ($ MILLION)

TABLE 13: ASIA PACIFIC OTHER TECHNOLOGY MARKET, 2019-2027 ($ MILLION)

TABLE 14: ASIA PACIFIC MULTIPLEX ASSAY MARKET, BY APPLICATION, 2019-2027 ($ MILLION)

TABLE 15: ASIA PACIFIC CLINICAL DIAGNOSTICS MARKET, 2019-2027 ($ MILLION)

TABLE 16: ASIA PACIFIC RESEARCH AND DEVELOPMENT MARKET, 2019-2027 ($ MILLION)

TABLE 17: ASIA PACIFIC COMPANION DIAGNOSTICS MARKET, 2019-2027 ($ MILLION)

TABLE 18: ASIA PACIFIC MULTIPLEX ASSAY MARKET, BY END-USER, 2019-2027 ($ MILLION)

TABLE 19: ASIA PACIFIC HOSPITALS MARKET, 2019-2027 ($ MILLION)

TABLE 20: ASIA PACIFIC CLINICAL LABORATORIES MARKET, 2019-2027 ($ MILLION)

TABLE 21: ASIA PACIFIC RESEARCH INSTITUTES MARKET, 2019-2027 ($ MILLION)

TABLE 22: ASIA PACIFIC PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES MARKET, 2019-2027 ($ MILLION)

TABLE 23: ASIA PACIFIC MULTIPLEX ASSAY MARKET, BY COUNTRY, 2019-2027 ($ MILLION)

TABLE 24: JAPAN MULTIPLEX ASSAY MARKET, BY TYPE, 2019-2027 ($ MILLION)

TABLE 25: JAPAN MULTIPLEX ASSAY MARKET, BY PRODUCT, 2019-2027 ($ MILLION)

TABLE 26: JAPAN MULTIPLEX ASSAY MARKET, BY TECHNOLOGY, 2019-2027 ($ MILLION)

TABLE 27: JAPAN MULTIPLEX ASSAY MARKET, BY APPLICATION, 2019-2027 ($ MILLION)

TABLE 28: JAPAN MULTIPLEX ASSAY MARKET, BY END-USER, 2019-2027 ($ MILLION)

TABLE 29: CHINA MULTIPLEX ASSAY MARKET, BY TYPE, 2019-2027 ($ MILLION)

TABLE 30: CHINA MULTIPLEX ASSAY MARKET, BY PRODUCT, 2019-2027 ($ MILLION)

TABLE 31: CHINA MULTIPLEX ASSAY MARKET, BY TECHNOLOGY, 2019-2027 ($ MILLION)

TABLE 32: CHINA MULTIPLEX ASSAY MARKET, BY APPLICATION, 2019-2027 ($ MILLION)

TABLE 33: CHINA MULTIPLEX ASSAY MARKET, BY END-USER, 2019-2027 ($ MILLION)

TABLE 34: INDIA MULTIPLEX ASSAY MARKET, BY TYPE, 2019-2027 ($ MILLION)

TABLE 35: INDIA MULTIPLEX ASSAY MARKET, BY PRODUCT, 2019-2027 ($ MILLION)

TABLE 36: INDIA MULTIPLEX ASSAY MARKET, BY TECHNOLOGY, 2019-2027 ($ MILLION)

TABLE 37: INDIA MULTIPLEX ASSAY MARKET, BY APPLICATION, 2019-2027 ($ MILLION)

TABLE 38: INDIA MULTIPLEX ASSAY MARKET, BY END-USER, 2019-2027 ($ MILLION)

TABLE 39: SOUTH KOREA MULTIPLEX ASSAY MARKET, BY TYPE, 2019-2027 ($ MILLION)

TABLE 40: SOUTH KOREA MULTIPLEX ASSAY MARKET, BY PRODUCT, 2019-2027 ($ MILLION)

TABLE 41: SOUTH KOREA MULTIPLEX ASSAY MARKET, BY TECHNOLOGY, 2019-2027 ($ MILLION)

TABLE 42: SOUTH KOREA MULTIPLEX ASSAY MARKET, BY APPLICATION, 2019-2027 ($ MILLION)

TABLE 43: SOUTH KOREA MULTIPLEX ASSAY MARKET, BY END-USER, 2019-2027 ($ MILLION)

TABLE 44: AUSTRALIA MULTIPLEX ASSAY MARKET, BY TYPE, 2019-2027 ($ MILLION)

TABLE 45: AUSTRALIA MULTIPLEX ASSAY MARKET, BY PRODUCT, 2019-2027 ($ MILLION)

TABLE 46: AUSTRALIA MULTIPLEX ASSAY MARKET, BY TECHNOLOGY, 2019-2027 ($ MILLION)

TABLE 47: AUSTRALIA MULTIPLEX ASSAY MARKET, BY APPLICATION, 2019-2027 ($ MILLION)

TABLE 48: AUSTRALIA MULTIPLEX ASSAY MARKET, BY END-USER, 2019-2027 ($ MILLION)

LIST OF FIGURES

FIGURE 1: ASIA PACIFIC MULTIPLEX ASSAY MARKET, 2019-2027 ($ MILLION)

FIGURE 2: ASIA PACIFIC MULTIPLEX ASSAY MARKET SHARE, BY TYPE, 2018 & 2027 (%)

FIGURE 3: ASIA PACIFIC MULTIPLEX ASSAY MARKET, BY PROTEIN-BASED MULTIPLEX ASSAYS, 2019-2027 ($ MILLION)

FIGURE 4: ASIA PACIFIC MULTIPLEX ASSAY MARKET, BY NUCLEIC ACID-BASED MULTIPLEX ASSAYS, 2019-2027 ($ MILLION)

FIGURE 5: ASIA PACIFIC MULTIPLEX ASSAY MARKET, BY OTHER MULTIPLEX ASSAYS, 2019-2027 ($ MILLION)

FIGURE 6: ASIA PACIFIC MULTIPLEX ASSAY MARKET SHARE, BY PRODUCT, 2018 & 2027 (%)

FIGURE 7: ASIA PACIFIC MULTIPLEX ASSAY MARKET, BY REAGENTS AND CONSUMABLES, 2019-2027 ($ MILLION)

FIGURE 8: ASIA PACIFIC MULTIPLEX ASSAY MARKET, BY INSTRUMENTS AND ACCESSORIES, 2019-2027 ($ MILLION)

FIGURE 9: ASIA PACIFIC MULTIPLEX ASSAY MARKET, BY SOFTWARE AND SERVICES, 2019-2027 ($ MILLION)

FIGURE 10: ASIA PACIFIC MULTIPLEX ASSAY MARKET SHARE, BY TECHNOLOGY, 2018 & 2027 (%)

FIGURE 11: ASIA PACIFIC MULTIPLEX ASSAY MARKET, BY MULTIPLEX PROTEIN MICROARRAY, 2019-2027 ($ MILLION)

FIGURE 12: ASIA PACIFIC MULTIPLEX ASSAY MARKET, BY MULTIPLEX PCR, 2019-2027 ($ MILLION)

FIGURE 13: ADVANTAGES OF IMMUNOHISTOCHEMISTRY (IHC)

FIGURE 14: ASIA PACIFIC MULTIPLEX ASSAY MARKET, BY OTHER TECHNOLOGY, 2019-2027 ($ MILLION)

FIGURE 15: ASIA PACIFIC MULTIPLEX ASSAY MARKET SHARE, BY APPLICATION, 2018 & 2027 (%)

FIGURE 16: ASIA PACIFIC MULTIPLEX ASSAY MARKET, BY CLINICAL DIAGNOSTICS, 2019-2027 ($ MILLION)

FIGURE 17: ASIA PACIFIC MULTIPLEX ASSAY MARKET, BY RESEARCH AND DEVELOPMENT, 2019-2027 ($ MILLION)

FIGURE 18: ASIA PACIFIC MULTIPLEX ASSAY MARKET, BY COMPANION DIAGNOSTICS, 2019-2027 ($ MILLION)

FIGURE 19: ASIA PACIFIC MULTIPLEX ASSAY MARKET SHARE, BY END-USER, 2018 & 2027 (%)

FIGURE 20: ASIA PACIFIC MULTIPLEX ASSAY MARKET, BY HOSPITALS, 2019-2027 ($ MILLION)

FIGURE 21: ASIA PACIFIC MULTIPLEX ASSAY MARKET, BY CLINICAL LABORATORIES, 2019-2027 ($ MILLION)

FIGURE 22: ASIA PACIFIC MULTIPLEX ASSAY MARKET, BY RESEARCH INSTITUTES, 2019-2027 ($ MILLION)

FIGURE 23: ASIA PACIFIC MULTIPLEX ASSAY MARKET, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2019-2027 ($ MILLION)

FIGURE 24: PORTER’S FIVE FORCE MODEL

FIGURE 25: KEY BUYING CRITERIA

FIGURE 26: NEWLY REGISTERED CLINICAL TRIAL STUDY 2016-2018

FIGURE 27: JAPAN MULTIPLEX ASSAY MARKET, 2019-2027 ($ MILLION)

FIGURE 28: CHINA MULTIPLEX ASSAY MARKET, 2019-2027 ($ MILLION)

FIGURE 29: INDIA MULTIPLEX ASSAY MARKET, 2019-2027 ($ MILLION)

FIGURE 30: SOUTH KOREA MULTIPLEX ASSAY MARKET, 2019-2027 ($ MILLION)

FIGURE 31: AUSTRALIA MULTIPLEX ASSAY MARKET, 2019-2027 ($ MILLION)

FIGURE 32: REST OF ASIA-PACIFIC MULTIPLEX ASSAY MARKET, 2019-2027 ($ MILLION)

FIGURE 33: MULTIPLEX ASSAY COMPANY MARKET SHARE ANALYSIS, 2018 (%)

  1. GEOGRAPHICAL ANALYSIS
    • ASIA PACIFIC
      • JAPAN
      • CHINA
      • INDIA
      • SOUTH KOREA
      • AUSTRALIA
      • REST OF ASIA-PACIFIC
  1. MARKET BY TYPE
    • PROTEIN-BASED MULTIPLEX ASSAYS
    • NUCLEIC ACID-BASED MULTIPLEX ASSAYS
    • OTHER MULTIPLEX ASSAYS
  2. MARKET BY PRODUCT
    • REAGENTS AND CONSUMABLES
    • INSTRUMENTS AND ACCESSORIES
    • SOFTWARE AND SERVICES
  3. MARKET BY TECHNOLOGY
    • MULTIPLEX PROTEIN MICROARRAY
    • MULTIPLEX PCR
    • OTHER TECHNOLOGY
  4. MARKET BY APPLICATION
    • CLINICAL DIAGNOSTICS
    • RESEARCH AND DEVELOPMENT
    • COMPANION DIAGNOSTICS
  5. MARKET BY END-USER
    • HOSPITALS
    • CLINICAL LABORATORIES
    • RESEARCH INSTITUTES
    • PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES

To request a free sample copy of this report, please complete the form below :
We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.

Choose License Type

Buy Now